Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Molecular Pharmacology

• Publication date

  2004-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/MOL.104.000398PMID 15266022
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns.

  2004cited by this paper
• Cell Surface Expression of α1D-Adrenergic Receptors Is Controlled by Heterodimerization with α1B-Adrenergic Receptors*

  2004cited by this paper
• Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors.

  2004cited by this paper
• Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis.

  2003influential reference
• Activation of the Leptin Receptor by a Ligand-induced Conformational Change of Constitutive Receptor Dimers*

  2003influential reference
• New selective ligands of human cloned melatonin MT1 and MT2 receptors

  2003influential reference
• Measurement of the millisecond activation switch of G protein–coupled receptors in living cells

  2003cited by this paper
• No Ligand Binding in the GB2 Subunit of the GABABReceptor Is Required for Activation and Allosteric Interaction between the Subunits

  2002cited by this paper
• Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer.

  2002influential reference
• Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210

  2002cited by this paper
• Measuring protein conformational changes by FRET/LRET.

  2002influential reference
• Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells

  2002cited by this paper
• Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer*

  2002influential reference
• The ligand paradox between affinity and efficacy: can you be there and not make a difference?

  2002cited by this paper
• Formation of oligomers by G protein-coupled receptors.

  2002cited by this paper
• Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210

  2002influential reference
• Agonist-induced conformational changes in the G-protein-coupling domain of the β2 adrenergic receptor

  2001cited by this paper
• Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer

  2001cited by this paper
• Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes.

  2001cited by this paper
• The use of FRET imaging microscopy to detect protein-protein interactions and protein conformational changes in vivo.

  2001influential reference
• Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer.

  2001influential reference
• Homo- and Heterodimerization of Somatostatin Receptor Subtypes

  2001cited by this paper
• Melatonin Receptor Signaling: Finding the Path Through the Dark

  2001cited by this paper
• Constitutive and Agonist-dependent Homo-oligomerization of the Thyrotropin-releasing Hormone Receptor

  2001influential reference
• Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).

  2000influential reference
• Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

  2000influential reference
• Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers*

  2000influential reference
• Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

  2000cited by this paper
• Investigation of the human Mel 1a melatonin receptor using anti-receptor antibodies.

  1999cited by this paper
• G-protein-coupled receptor heterodimerization modulates receptor function

  1999influential reference
• Tight association of the human Mel(1a)-melatonin receptor and G(i): precoupling and constitutive activity.

  1999cited by this paper
• Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins.

  1999cited by this paper
• Characterization of 2-[125I]iodomelatonin binding sites in Syrian hamster peripheral organs.

  1999cited by this paper
• Investigation of the human Mel 1a melatonin receptor using anti-receptor antibodies.

  1999cited by this paper
• Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathway.

  1999cited by this paper
• Adenosine A1 Receptor-mediated Modulation of Dopamine D1 Receptors in Stably Cotransfected Fibroblast Cells*

  1998cited by this paper
• GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2

  1998cited by this paper
• Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor

  1997cited by this paper
• Conformational changes of the insulin receptor upon insulin binding and activation as monitored by fluorescence spectroscopy.

  1997cited by this paper
• Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin

  1996cited by this paper
• Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery.

  1995cited by this paper
• Melatonin receptors: localization, molecular pharmacology and physiological significance.

  1994cited by this paper
• Putative melatonin receptors in a human biological clock.

  1988cited by this paper
• Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina.

  1987cited by this paper
• Melatonin is a potent modulator of dopamine release in the retina

  1983cited by this paper

• Cellular signalling of melatonin and its role in metabolic disorders

  2025cites this paper
• High mobility group box 1, a novel serotonin receptor-7 negative modulator, contributes to M2 microglial ferroptosis and neuroinflammation in post-stroke depression.

  2025cites this paper
• GPCR Heterodimers: Implications for Biased Signaling.

  2025cites this paper
• Melatonin receptors in GtoPdb v.2025.3

  2025cites this paper
• Melatonin, modulation of hypothalamic activity, and reproduction.

  2025cites this paper
• Phylogenetic and Structural Insights into Melatonin Receptors in Plants: Case Study in Capsicum chinense Jacq

  2025cites this paper
• Melatonin receptor structure and signaling

  2024cites this paper
• Sperm melatonin receptors, seminal plasma melatonin and semen freezability in goats.

  2024cites this paper
• Modulation of autophagy by melatonin and its receptors: implications in brain disorders

  2024cites this paper
• Unveiling the stochastic nature of human heteropolymer ferritin self‐assembly mechanism

  2024cites this paper
• Melatonin in the mammalian retina: Synthesis, mechanisms of action and neuroprotection

  2024cites this paper
• Molecular Characterization and Pharmacology of Melatonin Receptors in Animals

  2023influential citation
• Melatonin receptors in GtoPdb v.2023.1 Melatonin receptors in GtoPdb v.2023.1

  2023cites this paper
• Astrocyte-Ablation of Mtnr1b Increases Anxiety-Like Behavior in Adult Male Mice.

  2023cites this paper
• Mitochondria-targeted melatonin photorelease supports the presence of melatonin MT1 receptors in mitochondria inhibiting respiration.

  2023cites this paper
• Class A and C GPCR Dimers in Neurodegenerative Diseases

  2022cites this paper
• Migraine signaling pathways: amino acid metabolites that regulate migraine and predispose migraineurs to headache

  2022cites this paper
• Luminogenic HiBiT Peptide-Based NanoBRET Ligand Binding Assays for Melatonin Receptors.

  2022cites this paper
• Design and Validation of the First Family of Photo-Activatable Ligands for Melatonin Receptors

  2022cites this paper
• Measuring Protein-Protein Interactions of Melatonin Receptors by Bioluminescence Resonance Energy Transfer (BRET).

  2022cites this paper
• Melatonin Receptors: A Key Mediator in Animal Reproduction

  2022cites this paper
• Assessment of the Therapeutic Potential of Melatonin for the Treatment of Osteoporosis Through a Narrative Review of Its Signaling and Preclinical and Clinical Studies

  2022cites this paper
• Bos taurus and Cervus elaphus as Non-Seasonal/Seasonal Models for the Role of Melatonin Receptors in the Spermatozoon

  2022cites this paper
• Physiology and Pharmacology of Melatonin

  2021cites this paper
• Modeling the Heterodimer Interfaces of Melatonin Receptors

  2021cites this paper
• A Putative New Melatonin Binding Site in Sheep Brain, MTx: Preliminary Observations and Characteristics

  2021cites this paper
• Melatonin receptor 1A, but not 1B, knockout decreases biliary damage and liver fibrosis during cholestatic liver injury

  2021cites this paper
• Membrane Melatonin Receptors Activated Cell Signaling in Physiology and Disease

  2021cites this paper
• G protein-coupled receptor-effector macromolecular membrane assemblies (GEMMAs).

  2021cites this paper
• Investigation of Receptor Heteromers Using NanoBRET Ligand Binding

  2021cites this paper
• G-protein coupled receptors and synaptic plasticity in sleep deprivation

  2021cites this paper
• Melatonin interrupts osteoclast functioning and suppresses tumor-secreted RANKL expression: implications for bone metastases

  2021cites this paper
• Multiple GPCR Functional Assays Based on Resonance Energy Transfer Sensors

  2021cites this paper
• Influence of Circadian Rhythm in the Eye: Significance of Melatonin in Glaucoma

  2021cites this paper
• Melatonin and the control of intraocular pressure.

  2020cites this paper
• Pharmacological evidence for transactivation within melatonin MT2 and serotonin 5‐HT2C receptor heteromers in mouse brain

  2020cites this paper
• Purification and Identification of G Protein-coupled Receptor Protein Complexes under Native Conditions*

  2020cites this paper
• Deletion of ferritin H in neurons counteracts the protective effect of melatonin against traumatic brain injury‐induced ferroptosis

  2020cites this paper
• Adreno–melatonin receptor complexes control ion homeostasis and intraocular pressure ‐ their disruption contributes to hypertensive glaucoma

  2020cites this paper
• Melatonin membrane receptors MT1 and MT2 are expressed in ram spermatozoa from non-seasonal breeds

  2020cites this paper
• Pharmacology of Melatonin and Its Receptors

  2020cites this paper
• O-linked melatonin dimers as bivalent ligands targeting dimeric melatonin receptors.

  2019cites this paper
• The five dimensions of receptor pharmacology exemplified by melatonin receptors: An opinion

  2019cites this paper
• Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives.

  2019cites this paper
• Melatonin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Two indoleamines are secreted from rat pineal gland at night and act on melatonin receptors but are not night hormones

  2019cites this paper
• Reinterpreting anomalous competitive binding experiments within G protein‐coupled receptor homodimers using a dimer receptor model

  2019cites this paper
• The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?

  2019cites this paper
• Melatonin: Implications for Ocular Disease and Therapeutic Potential.

  2019cites this paper
• The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome.

  2019cites this paper
• Allosteric interactions between catecholamine receptors and other G protein-coupled receptors: Pharmacological and functional characterization

  2018cites this paper
• Importance of the second extracellular loop for melatonin MT1 receptor function and absence of melatonin binding in GPR50

  2018cites this paper
• Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function.

  2018cites this paper
• Differential Regulation of Cell Proliferation and Apoptosis by Melatonin Receptor Subtype-Signaling in the Adult Murine Brain

  2018cites this paper
• Receptor–Receptor Interactions of G Protein-Coupled Receptors in the Carotid Body: A Working Hypothesis

  2018cites this paper
• Melatonin receptors limit dopamine reuptake by regulating dopamine transporter cell-surface exposure

  2018cites this paper
• Decoding the signaling of the D2R-2AR heteromer: relevance to schizophrenia

  2018cites this paper
• Receptor‐specific crosstalk between prostanoid E receptor 3 and bombesin receptor subtype 3

  2018cites this paper
• Melatonin receptors: molecular pharmacology and signalling in the context of system bias

  2018cites this paper
• Design and validation of the first cell‐impermeant melatonin receptor agonist

  2017cites this paper
• Melatonin MT1 and MT2 Receptors in the Ram Reproductive Tract

  2017cites this paper
• Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms.

  2017cites this paper
• Dimerization of complement C5a receptors in inflammatory responses

  2017influential citation
• Melatonin transport into mitochondria

  2017cites this paper
• Role of the MT1 and MT2 melatonin receptors in mediating depressive‐ and anxiety‐like behaviors in C3H/HeN mice

  2017cites this paper
• Rolle einer Melatoninrezeptoraktivierung für die hepatische Mikrozirkulation nach polymikrobieller Sepsis in der Maus

  2016cites this paper
• Biophysical insights into the molecular pharmacology of angiotensin II receptor heteromers

  2016cites this paper
• Update on melatonin receptors: IUPHAR Review 20

  2016cites this paper
• Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

  2016cites this paper
• Quinone reductase 2 as a promising target of melatonin therapeutic actions

  2016cites this paper
• 1 MELATONIN RECEPTORS MT 1 AND MT 2 ARE EXPRESED IN 1 SPERMATOZOA FROM SEVERAL SEASONAL AND NON-SEASONAL 2 BREEDER SPECIES 3 4

  2016cites this paper
• Melatonin Signaling Controls the Daily Rhythm in Blood Glucose Levels Independent of Peripheral Clocks

  2016cites this paper
• Melatonin receptors MT1 and MT2 are expressed in spermatozoa from several seasonal and nonseasonal breeder species.

  2016cites this paper
• Cone Viability Is Affected by Disruption of Melatonin Receptors Signaling

  2016cites this paper
• Resonance Energy Transfer-Based Approaches to Study GPCRs.

  2016influential citation
• MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.

  2016cites this paper
• G Protein-Coupled Receptor Heteromers.

  2016cites this paper
• Amyloid β peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway

  2015cites this paper
• Resveratrol: brain effects on SIRT1, GPR50 and photoperiodic signaling

  2015cites this paper
• Experimental and clinical aspects of melatonin and clock genes in diabetes

  2015cites this paper
• Synthesis and role of melatonin in the retina of rodents

  2015cites this paper
• Neuroendocrine control of photoperiodic changes in immune function.

  2015cites this paper
• Melatonin Receptors Trigger cAMP Production and Inhibit Chloride Movements in Nonpigmented Ciliary Epithelial Cells

  2015cites this paper
• A role for melatonin in maintaining the pro- and anti-inflammatory balance by influencing leukocyte migration and apoptosis in carp.

  2015cites this paper
• Structure-based algorithms for protein-protein interactions

  2014cites this paper
• Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders

  2014cites this paper
• Distribution of MT1 Melatonin Receptor Promoter-Driven RFP Expression in the Brains of BAC C3H/HeN Transgenic Mice

  2014cites this paper
• Circadian organization of the mammalian retina: from gene regulation to physiology and diseases.

  2014cites this paper
• Synthetic Melatoninergic Ligands: Achievements and Prospects

  2014cites this paper
• Melatonin in sperm biology: breaking paradigms.

  2014cites this paper
• Role of Melatonin and Dopamine in the Regulation of Retinal Circadian Rhythms

  2014cites this paper
• MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.

  2014cites this paper
• Understanding melatonin receptor pharmacology: Latest insights from mouse models, and their relevance to human disease

  2014cites this paper
• Application of BRET for studying G protein-coupled receptors.

  2014cites this paper
• Melatonin MT1 and MT2 receptors display different molecular pharmacologies only in the G‐protein coupled state

  2014cites this paper
• Demonstration of a Direct Interaction between β2-Adrenergic Receptor and Insulin Receptor by BRET and Bioinformatics

  2014cites this paper
• Hormone-free protocols for the control of reproduction and artificial insemination in goats.

  2014cites this paper
• Differential Expression of Melatonin Receptor Subtypes MelIa, MelIb and MelIc in Relation to Melatonin Binding in the Male Songbird Brain

  2014cites this paper
• Title Receptor oligomerization : from early evidence to currentunderstanding in class B GPCRs

  2013cites this paper
• The orphan 7TM protein GPR50 as a novel regulator of TGFβ signal transduction

  2013cites this paper